This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bau, D.-T. Articles by Shen, C.-Y. Search for Related Content PubMed PubMed Citation Articles by Bau, D.-T. Articles by Shen, C.-Y.

Breast Cancer Risk and the DNA Double-Strand Break End-Joining Capacity of Nonhomologous End-Joining Genes Are Affected by BRCA1

¹ Institute of Biomedical Sciences and ² Life Science Library, Academia Sinica, Taipei; ³ Department of Surgery, Changhua Christian Hospital, Changhua; and ⁴ Department of Surgery, Tri-Service General Hospital, Taipei, Taiwan

A tumorigenic role of the nonhomologous end-joining (NHEJ) pathway for the repair of DNA double-strand breaks (DSBs) has been suggested by the finding of a significant association between increased breast cancer risk and a cooperative effect of single nucleotide polymorphisms (SNPs) in NHEJ genes. However, the lack of an association between hereditary breast cancer and defective NHEJ genes prevents conclusions from being drawn about a link between NHEJ and breast cancer development. Recently, BRCA1-deficient mouse embryonic fibroblasts were found to have significantly reduced NHEJ activity, suggesting an accessory role of BRCA1 in NHEJ. The present study was performed to confirm this observation in human breast cancer cell lines and to examine whether the interaction between BRCA1 and NHEJ was of tumorigenic significance. Support for this hypothesis came from the findings that (a) a case-control study (469 breast cancer patients and 740 healthy controls) showed that the breast cancer risk associated with high-risk genotypes of NHEJ genes was significantly modified by the BRCA1 genotype. A significant increase in the cancer risk associated either with harboring one additional putative high-risk NHEJ genotype or with the joint effect of having reproductive risk factors (reflected by an interval of 12 years between menarche and first full-term pregnancy) and a higher number of high-risk genotypes of the NHEJ genes was only seen in women with at least one variant BRCA1 allele (i.e., the Glu/Gly or Gly/Gly forms of BRCA1 Glu¹⁰³⁸Gly); and (b) a phenotype-based study measuring in vitro and in vivo NHEJ capacity showed that the precise end-joining capacity was different in breast cancer cell lines with different BRCA1 statuses being higher in BRCA1-expressing MCF-7 cells than in HCC1937 cells (defective BRCA1 expression). Furthermore, this end-joining capacity was decreased in MCF-7 cells in which BRCA1 expression was blocked using small interfering RNA and increased in HCC1937 transfected with full-length BRCA1. Because BRCA1 is a well-documented breast cancer susceptibility gene, this association between NHEJ and BRCA1 not only suggests a role of BRCA1 in NHEJ but also provides essential support for the tumorigenic contribution of NHEJ in breast cancer development.

This article has been cited by other articles:

				H.-C. WANG, C.-F. CHIU, R.-Y. TSAI, Y.-S. KUO, H.-S. CHEN, R.-F. WANG, C.-W. TSAI, C.-H. CHANG, C.-C. LIN, and D.-T. BAU Association of Genetic Polymorphisms of EXO1 Gene with Risk of Breast Cancer in Taiwan Anticancer Res, October 1, 2009; 29(10): 3897 - 3901. [Abstract] [Full Text] [PDF]

				M.-D. YANG, Y.-M. HSU, Y.-S. KUO, H.-S. CHEN, C.-L. CHANG, C.-N. WU, C.-H. CHANG, Y.-M. LIAO, H.-C. WANG, M.-F. WANG, et al. Significant Association of Ku80 Single Nucleotide Polymorphisms with Colorectal Cancer Susceptibility in Central Taiwan Anticancer Res, June 1, 2009; 29(6): 2239 - 2242. [Abstract] [Full Text] [PDF]

				S.-l. Ding, J.-C. Yu, S.-T. Chen, G.-C. Hsu, S.-J. Kuo, Y. H. Lin, P.-E. Wu, and C.-Y. Shen Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility Carcinogenesis, January 1, 2009; 30(1): 43 - 49. [Abstract] [Full Text] [PDF]

				L. Wei, L. Lan, Z. Hong, A. Yasui, C. Ishioka, and N. Chiba Rapid Recruitment of BRCA1 to DNA Double-Strand Breaks Is Dependent on Its Association with Ku80 Mol. Cell. Biol., December 15, 2008; 28(24): 7380 - 7393. [Abstract] [Full Text] [PDF]

				N. Machella, M. B. Terry, J. Zipprich, I. Gurvich, Y. Liao, R. T. Senie, D. O. Kennedy, and R. M. Santella Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR Carcinogenesis, July 1, 2008; 29(7): 1367 - 1372. [Abstract] [Full Text] [PDF]

				H.-M. Hsu, H.-C. Wang, S.-T. Chen, G.-C. Hsu, C.-Y. Shen, and J.-C. Yu Breast Cancer Risk Is Associated with the Genes Encoding the DNA Double-Strand Break Repair Mre11/Rad50/Nbs1 Complex Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2024 - 2032. [Abstract] [Full Text] [PDF]

				D.-T. Bau, Y.-C. Mau, S.-l. Ding, P.-E. Wu, and C.-Y. Shen DNA double-strand break repair capacity and risk of breast cancer Carcinogenesis, August 1, 2007; 28(8): 1726 - 1730. [Abstract] [Full Text] [PDF]

				S. Kuhfittig-Kulle, E. Feldmann, A. Odersky, A. Kuliczkowska, W. Goedecke, A. Eggert, and P. Pfeiffer The mutagenic potential of non-homologous end joining in the absence of the NHEJ core factors Ku70/80, DNA-PKcs and XRCC4-LigIV Mutagenesis, May 1, 2007; 22(3): 217 - 233. [Abstract] [Full Text] [PDF]

				S.-l. Ding, J.-C. Yu, S.-T. Chen, G.-C. Hsu, and C.-Y. Shen Genetic Variation in the Premature Aging Gene WRN: A Case-Control Study on Breast Cancer Susceptibility Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 263 - 269. [Abstract] [Full Text] [PDF]

				C. DelloRusso, P. L. Welcsh, W. Wang, R. L. Garcia, M.-C. King, and E. M. Swisher Functional Characterization of a Novel BRCA1-Null Ovarian Cancer Cell Line in Response to Ionizing Radiation Mol. Cancer Res., January 1, 2007; 5(1): 35 - 45. [Abstract] [Full Text] [PDF]

				K. Allen-Brady, L. A. Cannon-Albright, S. L. Neuhausen, and N. J. Camp A Role for XRCC4 in Age at Diagnosis and Breast Cancer Risk. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1306 - 1310. [Abstract] [Full Text] [PDF]

				H.-C. Wang, W.-C. Chou, S.-Y. Shieh, and C.-Y. Shen Ataxia Telangiectasia Mutated and Checkpoint Kinase 2 Regulate BRCA1 to Promote the Fidelity of DNA End-Joining Cancer Res., February 1, 2006; 66(3): 1391 - 1400. [Abstract] [Full Text] [PDF]

				J. Zhuang, J. Zhang, H. Willers, H. Wang, J. H. Chung, D. C. van Gent, D. E. Hallahan, S. N. Powell, and F. Xia Checkpoint Kinase 2-Mediated Phosphorylation of BRCA1 Regulates the Fidelity of Nonhomologous End-Joining Cancer Res., February 1, 2006; 66(3): 1401 - 1408. [Abstract] [Full Text] [PDF]

				E. Honrado, A. Osorio, J. Palacios, R. L. Milne, L. Sanchez, O. Diez, A. Cazorla, K. Syrjakoski, D. Huntsman, P. Heikkila, et al. Immunohistochemical Expression of DNA Repair Proteins in Familial Breast Cancer Differentiate BRCA2-Associated Tumors J. Clin. Oncol., October 20, 2005; 23(30): 7503 - 7511. [Abstract] [Full Text] [PDF]

				J. Zhang and S. N. Powell The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair Mol. Cancer Res., October 1, 2005; 3(10): 531 - 539. [Abstract] [Full Text] [PDF]

				M. L. Freedman, K. L. Penney, D. O. Stram, S. Riley, R. McKean-Cowdin, L. Le Marchand, D. Altshuler, and C. A. Haiman A Haplotype-Based Case-Control Study of BRCA1 and Sporadic Breast Cancer Risk Cancer Res., August 15, 2005; 65(16): 7516 - 7522. [Abstract] [Full Text] [PDF]